+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ribozyme"

Nucleic Acid Based Gene Therapy Global Market Report 2024 - Product Thumbnail Image

Nucleic Acid Based Gene Therapy Global Market Report 2024

  • Report
  • November 2023
  • 250 Pages
  • Global
From
From
From
From
From
From
From
RNAi - Technologies, Markets & Companies - Product Thumbnail Image

RNAi - Technologies, Markets & Companies

  • Report
  • November 2021
  • 527 Pages
  • Global
From
Gene Therapy - Technologies, Markets & Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets & Companies

  • Report
  • November 2021
  • 802 Pages
  • Global
From
Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

  • Report
  • November 2021
  • 1184 Pages
  • Global
From
From
  • 19 Results (Page 1 of 1)
Loading Indicator

Ribozyme is a type of RNA molecule that can act as a catalyst in biochemical reactions. It is used in genomics to study gene expression, protein synthesis, and other cellular processes. Ribozymes are also used in gene therapy, as they can be used to target and cleave specific mRNA molecules. Ribozymes are also used in the development of new drugs, as they can be used to target and inhibit specific proteins. Ribozyme technology has been used in a variety of research applications, including the study of gene regulation, protein-protein interactions, and the development of new therapeutic agents. The market for ribozymes is expected to grow in the coming years, as the technology is increasingly used in the development of new drugs and therapies. Some companies in the ribozyme market include Twist Bioscience, Ribozyme Pharmaceuticals, and Ribozyme Technologies. Show Less Read more